Figure 1.

Distribution of Responses to ED Single Item Proxy Overall and by Diabetes Status
* 9 (1.6%) additional participants added to cohort of participants with ED based on criteria of PDE5-Inhibitor use

Distribution of Responses to ED Single Item Proxy Overall and by Diabetes Status
* 9 (1.6%) additional participants added to cohort of participants with ED based on criteria of PDE5-Inhibitor use